The Eastern European Cancer Market Outlook to 2010 is a new management report which provides an in-depth analysis of growth brands, product sales forecasts, epidemiology and future market leaders over the period 2005-2010 in twelve major Eastern European cancer markets, including Hungary, Poland, the Czech Republic, Russian Federation, Slovenia, Slovakia and the Ukraine.

With a sales increase of over $0.5bn in the past five years, the Eastern European cancer market represents a strong opportunity for pharmaceutical marketers offering high levels of sales growth and market potential for a diversity of cancer products. The complexion of the Eastern European market is changing however and there currently exists a vibrant market for sales of innovative therapies, which have the potential for high rates of market penetration.

Tap into the growing market for innovative cancer therapies in Eastern Europe by using this latest report to identify the cancer market trends in developed and emerging Eastern European countries, assess the dominant therapies driving market growth and develop potential growth and diversification strategies in this region over the period 2005-2010.